The GLP is committed to full transparency. Download and review our just-released 2019 Annual Report.

Viewpoint: I wish I learned about my breast cancer risk from a genetic counselor instead of 23andMe

| | August 20, 2019

I opened the email from 23andMe, saying a report was ready for me to read. That click changed my life forever: To my utter shock, the results showed that I have a mutation in a gene called BRCA1, which puts me at a huge risk of developing breast and ovarian cancer. I broke into tears.

I’m not the first person to get surprising and terrible news from an at-home genetic testing company. With the increasing popularity of 23andMe, and other companies like it, I won’t be the last.

At Cedars-Sinai, my doctor said I shouldn’t make any decisions based on the 23andMe test. While the company says its reports are 99% accurate, most doctors want confirmation from a second source. So she introduced me to a genetic counselor.

Talking to someone about the results versus reading them in an online report — even after wading through a long tutorial — was the difference between day and night. 

I believe that knowledge is power and I’m glad I can read the story my genes have to tell. I just wish that everyone could have an interpreter when the story turns dark.

Read full, original post: 23andMe had devastating news about my health. I wish a person had delivered it

Related article:  Precision medicine inches along
The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend